Campbell & Co Investment Adviser’s Acorda Therapeutics ACOR Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-106	Closed	-$423K	–	260
2015 Q1	$423K	Buy	+106	New	+$485K	0.27%	138
2014 Q4	–	Sell	-180	Closed	-$733K	–	291
2014 Q3	$733K	Buy	+180	New	+$675K	0.38%	91
2014 Q1	–	Sell	-608	Closed	-$2.13M	–	316
2013 Q4	$2.13M	Buy	608 +65	+12%	+$253K	0.48%	76
2013 Q3	$2.23M	Buy	+543	New	+$2.34M	0.44%	78

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Campbell & Co Investment Adviser's ACOR Position: Q2 2015 in Review

Campbell & Co Investment Adviser sold out of Acorda Therapeutics (ACOR) in Q2 2015, closing a stake of 106 shares — an estimated $423K sold.

Campbell & Co Investment Adviser first reported a position in ACOR in Q3 2013 and held it in 4 quarters. The position peaked at $2.23M in Q3 2013. 170 funds tracked by Wall St. Rank hold ACOR as of Q2 2015.

Campbell & Co Investment Adviser reported no remaining Acorda Therapeutics position as of Q2 2015 after selling out during the quarter.
Campbell & Co Investment Adviser sold 106 Acorda Therapeutics shares in Q2 2015, an estimated $423K.
Campbell & Co Investment Adviser first reported a position in Acorda Therapeutics in Q3 2013 and held it in 4 quarters.
Campbell & Co Investment Adviser's Acorda Therapeutics position peaked at $2.23M in Q3 2013.
170 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2015.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2015, filed 7 Aug 2015.